Proposed Data Collection Submitted for Public Comment and Recommendations, 14731-14732 [2017-05699]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation. The Council did not have a
quorum for the meeting scheduled for
March 24th. Therefore, AHRQ is
cancelling the meeting. The next
meeting of the NAC is planned for July
26th.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–05588 Filed 3–21–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60-Day–17–17XR; Docket No. CDC–2017–
0027]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the donor registration form
in support of the project titled
‘‘Acquisition of Freshly Drawn Whole
Blood/Blood Products for Reference
Diagnostic and Research Use.’’
DATES: Written comments must be
received on or before May 22, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0027 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:14 Mar 21, 2017
Jkt 241001
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
14731
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Acquisition of Freshly-Drawn Whole
Blood/Blood Products for Reference
Diagnostic and Research Use—Existing
Information Collection in Use Without
an OMB Control Number—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The CDC seeks a three-year OMB
approval to collect information in
support of fresh blood/blood products
for laboratory programs.
The CDC regularly requires freshly
drawn whole blood, serum, plasma,
mononuclear white cell and platelet
concentrates for research purposes, for
reagents, and as ‘‘normal’’ control
materials. To enhance the safety of CDC
personnel handling these materials, the
blood/blood products, or the donors
thereof, must be screened for evidence
of possible infections by specific testing.
At the same time, donor confidentiality
must be assured and adequate
counseling must be available, in case
any specimens or donors test positive
for certain transmissible infections.
The donor registration form
referenced by this request is a brief, 11question form that establishes the
availability of volunteer donors to
participate in the donor program to fill
this need for fresh blood/blood products
for CDC. The registration form captures
donors’ availability to donate, interest in
various types of donations, smoking
history, exercise background, alcohol
consumption, measles vaccination
history, cholesterol test history, and
medications background.
Donors required to maintain the CDC
donor pool are recruited by contract
program managers often by referral of
current donors, directed outreach for
new donors by email, occasional posting
of notices in areas frequented by CDC
personnel, or at local universities for
possible student populations.
All donor information is collected and
protected by medical professionals with
donor/patient confidentiality protected.
Information from this form is only used
to determine donor eligibility for blood
product requests to be used by CDC
laboratory programs. Approximately 25
volunteer donors are enrolled annually.
E:\FR\FM\22MRN1.SGM
22MRN1
14732
Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices
There is no cost to respondents other
than the time to participate. Authorizing
legislation comes from Section 301 of
the Public Health Service Act (42 U.S.C.
241).
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hrs.)
Total burden
(in hrs.)
Type of respondents
Form name
General public ...................................
Registration ......................................
25
1
15/60
7
Total ...........................................
...........................................................
........................
........................
........................
7
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–05699 Filed 3–21–17; 8:45 am]
BILLING CODE 4163–18–P
Table of Contents:
•
•
•
•
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
World Trade Center Health Program;
Request for Nominations of Scientific
Peer Reviewers of Proposed Additions
to the List of WTC-Related Health
Conditions
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for scientific peer
reviewers.
AGENCY:
The CDC is soliciting
nominations, including selfnominations, for scientific peer
reviewers of proposed additions of
conditions to the List of World Trade
Center (WTC)-Related Health
Conditions (List).
Title I of the James Zadroga 9/11
Health and Compensation Act of 2010,
Public Law 111–347 (Jan. 2, 2011),
amended by Public Law 114–113 (Dec.
18, 2015), added Title XXXIII to the
Public Health Service Act (PHS Act),
establishing the WTC Health Program
within HHS (42 U.S.C. 300mm to
300mm–61). When the Administrator
proposes to add a condition to the List,
he must publish the proposed rule in
accordance with the Administrative
Procedure Act (5 U.S.C. 553).
Additionally, as required by the James
Zadroga 9/11 Health and Compensation
Reauthorization Act in section
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
18:14 Mar 21, 2017
Jkt 241001
Dates:
Addresses:
For Further Information Contact:
Supplementary Information:
Nominations must be submitted
(postmarked or electronically received)
by February 1, 2019.
ADDRESSES: You may submit a
nomination identified by NIOSH Docket
294, by any of the following methods.
• Electronic nominations, including
attachments to nioshdocket@cdc.gov.
• Regular, Express, or Overnight Mail:
Written nominations may be submitted
(one original and two copies) to the
following address only: NIOSH Docket
294, c/o Kiana Harper, National Institute
for Occupational Safety and Health,
Centers for Disease Control and
Prevention, Patriots Plaza 1, 95 E Street
SW., Suite 9200, Washington, DC 20201.
Telephone and facsimile submissions
cannot be accepted.
FOR FURTHER INFORMATION CONTACT: Paul
Middendorf, Ph.D., Deputy Associate
Director for Science, 1600 Clifton Rd.
NE., MS: E–20, Atlanta, GA 30329;
telephone (404)498–2500 (this is not a
toll-free number); email pmiddendorf@
cdc.gov.
Instructions: Nominations of peer
reviewers must be accompanied by:
• Name
• Occupation
• Employer
• Contact information including
mailing address, email, and phone
number
• Listing of scientific credentials
including academic degrees and
specialized training
• Area of competencies (e.g., medical,
epidemiology, exposure assessment,
industrial hygiene)
• Area of specialty (e.g.,
Cardiovascular, Integumentary,
DATES:
[Docket Number NIOSH–294]
VerDate Sep<11>2014
3312(a)(6)(F), prior to issuing a final
rule to add a health condition to the
List, the Administrator must provide for
an independent peer review of the
scientific and technical evidence that
would be the basis for issuing such final
rule.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Gastrointestinal, Endocrine, Urinary,
Immune, Lymphatic, Muscular,
Nervous, Reproductive, Respiratory,
Skeletal) Publication list
• Other materials to support the
nominee’s ability to perform scientific
peer review
• For third-party nominations,
affirmation from the nominee that they
are aware of and agree to the
nomination
A Curriculum vitae that includes all
of the above information may
alternatively be submitted.
SUPPLEMENTARY INFORMATION: The James
Zadroga 9/11 Health and Compensation
Reauthorization Act in section
3312(a)(6)(F) requires the Administrator
to provide for an independent peer
review of the scientific and technical
evidence that would be the basis for
issuing a final rule to add a health
condition to the List prior to issuing the
final rule. To assist in accomplishing
independent peer review in a timely
manner, the Administrator has
determined that he will develop a
standing pool of persons with the
scientific, technical, and medical
background to potentially serve in this
role to provide their individual input to
the Administrator based on the health
condition in the proposed rule under
consideration. The peer reviewers will
not meet as a group, provide consensus
advice or recommendations to the
Administrator, or produce a collective
work product(s). Therefore, the
Administrator is requesting nominations
of persons to serve as scientific peer
reviewers.
All persons who have the necessary
minimum qualifications will be
included in the standing pool of
potential peer reviewers. These persons
will be included in the standing pool of
potential peer reviewers for 3 years
unless they request in writing to be
removed. After 3 years persons may be
nominated again and will be required to
update their information.
The Administrator will select peer
reviewers for any proposed rule by
matching the nature of the proposed
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 82, Number 54 (Wednesday, March 22, 2017)]
[Notices]
[Pages 14731-14732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05699]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[60-Day-17-17XR; Docket No. CDC-2017-0027]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on the donor
registration form in support of the project titled ``Acquisition of
Freshly Drawn Whole Blood/Blood Products for Reference Diagnostic and
Research Use.''
DATES: Written comments must be received on or before May 22, 2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0027 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Acquisition of Freshly-Drawn Whole Blood/Blood Products for
Reference Diagnostic and Research Use--Existing Information Collection
in Use Without an OMB Control Number--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC seeks a three-year OMB approval to collect information in
support of fresh blood/blood products for laboratory programs.
The CDC regularly requires freshly drawn whole blood, serum,
plasma, mononuclear white cell and platelet concentrates for research
purposes, for reagents, and as ``normal'' control materials. To enhance
the safety of CDC personnel handling these materials, the blood/blood
products, or the donors thereof, must be screened for evidence of
possible infections by specific testing. At the same time, donor
confidentiality must be assured and adequate counseling must be
available, in case any specimens or donors test positive for certain
transmissible infections.
The donor registration form referenced by this request is a brief,
11-question form that establishes the availability of volunteer donors
to participate in the donor program to fill this need for fresh blood/
blood products for CDC. The registration form captures donors'
availability to donate, interest in various types of donations, smoking
history, exercise background, alcohol consumption, measles vaccination
history, cholesterol test history, and medications background.
Donors required to maintain the CDC donor pool are recruited by
contract program managers often by referral of current donors, directed
outreach for new donors by email, occasional posting of notices in
areas frequented by CDC personnel, or at local universities for
possible student populations.
All donor information is collected and protected by medical
professionals with donor/patient confidentiality protected. Information
from this form is only used to determine donor eligibility for blood
product requests to be used by CDC laboratory programs. Approximately
25 volunteer donors are enrolled annually.
[[Page 14732]]
There is no cost to respondents other than the time to participate.
Authorizing legislation comes from Section 301 of the Public Health
Service Act (42 U.S.C. 241).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
General public................ Registration.... 25 1 15/60 7
---------------
Total..................... ................ .............. .............. .............. 7
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-05699 Filed 3-21-17; 8:45 am]
BILLING CODE 4163-18-P
